research use only

Letermovir (AIC246) CMV inhibitor

Cat.No.S8873

Letermovir (AIC246, MK-8228) is a novel anti-CMV compound which targets the viral terminase complex and remains active against virus resistant to DNA polymerase inhibitors.
Jump to

Quality Control

Batch: S887301 DMSO]100 mg/mL]false]Ethanol]100 mg/mL]false]Water]Insoluble]false Purity: 99.87%
99.87

Solubility

In vitro
Batch:

DMSO : 100 mg/mL (174.65 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Ethanol : 100 mg/mL

Water : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 572.55 Formula

C29H28F4N4O4

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 917389-32-3 -- Storage of Stock Solutions

Synonyms MK-8228 SMILES COC1=C(C=C(C=C1)C(F)(F)F)N2C(C3=C(C(=CC=C3)F)N=C2N4CCN(CC4)C5=CC(=CC=C5)OC)CC(=O)O

Read more about storage stability stock solution CAS number SMILES

Mechanism of Action

In vitro

AIC246 blocks viral replication without inhibiting the synthesis of progeny HCMV DNA or viral proteins. It is one of the most potent anti-HCMV agents reported to date, with a cell culture EC50 in the one-digit nanomolar range (∼5 nM) and a selectivity index exceeding 15,000.

In vivo

AIC246 treatment leads to a dose-dependent reduction of the HCMV titer in transplanted cells compared to that of the placebo-treated control group using the mouse xenograft model.

References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2026-08-26)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT07706166 NOT_YET_RECRUITING
Kidney Transplant; Liver Transplant
University of Wisconsin, Madison
2026-09 PHASE4
NCT05446571 RECRUITING
Pregnant Women; CMV Infected Fetuses
Assistance Publique - Hôpitaux de Paris
2023-10-20 PHASE3
NCT05711667 RECRUITING
Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm
Children's Oncology Group
2024-07-11 PHASE3
NCT07571135 NOT_YET_RECRUITING
CMV Infection; CMV; CMV Viremia; CMV Disease
Elisabeth Kincaide
2026-05 PHASE4
NCT06575374 RECRUITING
Cell Therapy
M.D. Anderson Cancer Center
2024-12-12 PHASE2
NCT06453460 RECRUITING
CMV; Allogeneic Stem Cell Transplantation
University of California, Irvine
2024-06-27 PHASE2

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.